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Background
Muscular dystrophies comprise a heterogeneous group of
inherited diseases that are characterized by progressive
muscle weakness and degeneration. Severe forms, e.g.
Duchenne muscular dystrophy (DMD), which is caused
by a mutation in the dystrophin gene, lead to loss of
ambulation, respiratory failure, and premature death. In
many types of the muscular dystrophies the cardiac mus-
cle is also affected - cardiomyopathy and/or cardiac
arrhythmias regularly represent life threatening complica-
tions. The current understanding of the pathomechanisms
underlying these cardiac diseases in various muscular dys-
trophies is still very limited. Here we tested the hypothesis
that dysfunctional ion channels may be critically involved
in dystrophy-associated cardiac disease.
Methods
The functional properties of voltage-gated sodium and
calcium channels in cardiomyocytes derived from normal
and dystrophic neonatal mice were studied by using the
whole cell patch clamp technique. Besides the most com-
mon mouse model for human DMD, the dystrophin-defi-
cient mdx mouse, we also used mice additionally carrying
a mutation in the utrophin gene. The mdx-utr double
mutant mouse exhibits a more severe disease phenotype
than the mdx mouse, and may represent a more suitable
animal model for human DMD.
Results
We found that dystrophic cardiomyocytes show reduced
sodium current density compared to wild-type cardiomy-
ocytes. In addition, extra utrophin-deficiency altered
sodium channel activation and inactivation properties,
which was not observed in only dystrophin-deficient
(mdx) cardiomyocytes. Preliminary experiments also sug-
gest an impairment of calcium channel inactivation in
dystrophic cardiomyocytes.
Conclusion
We found significant impairments in ion channel func-
tion in dystrophic cardiomyocytes. These may perturb
electrical impulse propagation in the dystrophic heart,
and thus contribute to cardiac complications associated
with muscular dystrophies.
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